FDA 1 step closer to Pfizer COVID booster for age 16, 17

WASHINGTON, D.C. (AP) — The U.S. is a step closer to expanding COVID-19 boosters, ruling that 16- and 17-year-olds can get a third dose of Pfizer’s vaccine.The U.S. and many other nations already were urging adults to get booster shots to pump up immunity that can wane months after vaccination, calls that intensified with the discovery of the worrisome new omicron variant.On Thursday, the Food and Drug Administration gave emergency authorization for 16- and 17-year-olds to get a